search
Back to results

Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction) (SECRET-II)

Primary Purpose

Heart Failure, Diastolic, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
dietary, aerobic and resistance training
dietary, and aerobic exercise
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure, Diastolic focused on measuring Diastolic heart failure, Heart Failure, Elderly, Obesity

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 60 years or older
  2. Ejection fraction ≥ 50%
  3. Left Ventricular Diastolic Dysfunction ≥ grade 1
  4. BMI ≥ 28 kg/m2
  5. HF symptoms/ signs by cardiologist review, using NHANES HF Clinical Score >/= 3 or Rich et al. criteria for HF

Exclusion Criteria:

  1. Valvular heart disease as the primary etiology of CHF (congestive heart failure)
  2. Significant change in cardiac medication or Heart Failure symptoms <6 weeks
  3. Hospitalization or urgent care visit <6 weeks
  4. Uncontrolled hypertension
  5. Uncontrolled diabetes
  6. Evidence of significant Chronic Obstructive Pulmonary Disease (COPD)
  7. Recent or debilitating stroke
  8. Cancer or other noncardiovascular conditions with life expectancy less than 2 years
  9. Significant anemia (<10 g/dL Hgb)
  10. Significant renal insufficiency (eGFR <30 mL/min/1.73m2)
  11. Pregnant or of child-bearing potential
  12. Psychiatric disease- uncontrolled major psychoses, depressions, dementia, or personality disorder
  13. Plans to leave area within the study period
  14. Refuses informed consent -

Sites / Locations

  • Wake Forest Baptist Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

dietary, and aerobic exercise

dietary, aerobic and resistance training

Arm Description

Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training.

Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training. Intervention for resistance training- Additional weight resistant exercise will be added to this arm.

Outcomes

Primary Outcome Measures

Peak Exercise Oxygen Consumption (VO2)
Peak exercise oxygen consumption (VO2) pre and post intervention

Secondary Outcome Measures

Skeletal Muscle Mass
Measure skeletal muscle mass in kg by DEXA analysis pre and post intervention.
Thigh Skeletal Muscle Mass
Measure skeletal muscle mass by MRI analysis pre and post intervention.
Thigh Muscle Composition
MRI skeletal muscle to intermuscular fat ratio
Muscle Strength
maximal isokinetic knee extensor strength (Newton-meters, Nm) using an isokinetic dynamometer (Biodex®)
Muscle Quality
knee extensor strength to thigh muscle area assessed by MRI (Nm/cm2).
Quality of Life Measured by Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score
The KCCQ Overall Summary Summary Score is a heart failure disease-specific quality of life measure encompassing domains of physical limitation, HF symptoms, quality of life, and social limitation scored on a scale of 0-100 with higher scores indicating better health status.
Quality of Life Measured by Short Form 36 Item Questionnaire (SF-36)
The SF-36 is a quality of life assessment with 2 component scores (Physical Composite Score and Mental Composite Score) ranging 0-100 with higher scores indicating better health status.

Full Information

First Posted
December 9, 2015
Last Updated
July 8, 2022
Sponsor
Wake Forest University Health Sciences
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT02636439
Brief Title
Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)
Acronym
SECRET-II
Official Title
Study of the Effects Caloric Restriction and Exercise Training in Patients With Heart Failure and a Normal Ejection Fraction
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
August 2015 (Actual)
Primary Completion Date
July 21, 2021 (Actual)
Study Completion Date
July 21, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to examine the effects of weight loss via hypocaloric diet (CR)and aerobic exercise (AT) compared to the effects of weight loss via hypocaloric diet (CR), aerobic training (AT)and resistance training (RT).
Detailed Description
Heart failure with preserved ejection fraction (HFPEF) is the most common form of HF, is nearly unique to the older population, particularly older women, and is increasing in prevalence. Exercise intolerance, with severe exertional dyspnea and fatigue, is the primary manifestation of chronic HFPEF and is a major determinant of these patients' severely reduced quality of life (QOL). However, its pathophysiology is poorly understood and its optimal treatment remains undefined. Our recent data and others' indicate that in older HFPEF patients, both increased adiposity and abnormalities in skeletal muscle are major contributors to exercise intolerance and potential therapeutic targets. Obesity is one of the strongest risk factors for HFPEF, and is a robust predictor of physical disability in older persons. The investigator recently reported that in HFPEF compared to age-matched controls, percent total and leg lean mass are significantly reduced and independently predict exercise capacity. Using MRI and needle biopsy of the thigh muscle, the investigators found increased fat infiltration, reduced capillary density and percent type I oxidative fibers, and trends for reduced muscle mitochondrial mass and function. Reduced exercise capacity was related to each of these muscle abnormalities, supporting their important role in HFPEF. Diet, with or without aerobic exercise, can increase exercise capacity and quality of life in older obese persons with a variety of disorders, but usually results in significant loss of skeletal muscle mass, which could potentially have adverse long term consequences. The purpose of this trial is to determine if addition of resistance training to diet plus aerobic exercise training can improve skeletal muscle mass and function in HFPEF. Multiple lines of evidence and our preliminary data indicate that resistance training (RT) may be an ideal addition to CR+AT for HFPEF, since RT reliably increases muscle mass, quality, strength, and function, significantly more than AT, and can prevent nearly 50% of the muscle mass loss during CR. Therefore, the primary aim of the proposed study is to conduct a randomized, single-blinded 20-week intervention trial of RT added to CR+AT in 84 overweight / obese (BMI greater than 28 kg/m2), older (age greater than 60 years) HFPEF patients to test the following primary hypothesis: The addition of resistance training to CR+AT will improve exercise capacity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Diastolic, Obesity
Keywords
Diastolic heart failure, Heart Failure, Elderly, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
88 (Actual)

8. Arms, Groups, and Interventions

Arm Title
dietary, and aerobic exercise
Arm Type
Active Comparator
Arm Description
Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training.
Arm Title
dietary, aerobic and resistance training
Arm Type
Active Comparator
Arm Description
Intervention for diet-A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb.) weight loss per week. Intervention for aerobic exercise-Based on initial evaluations and the stress testing results, (HR, VO2, RPE) an individual exercise prescription will be developed for aerobic training. Intervention for resistance training- Additional weight resistant exercise will be added to this arm.
Intervention Type
Behavioral
Intervention Name(s)
dietary, aerobic and resistance training
Intervention Description
hypocaloric diet individual exercise prescription for aerobic training individual exercise prescription for resistance training.
Intervention Type
Behavioral
Intervention Name(s)
dietary, and aerobic exercise
Intervention Description
hypocaloric diet individual prescription for aerobic training.
Primary Outcome Measure Information:
Title
Peak Exercise Oxygen Consumption (VO2)
Description
Peak exercise oxygen consumption (VO2) pre and post intervention
Time Frame
20 weeks
Secondary Outcome Measure Information:
Title
Skeletal Muscle Mass
Description
Measure skeletal muscle mass in kg by DEXA analysis pre and post intervention.
Time Frame
20 weeks
Title
Thigh Skeletal Muscle Mass
Description
Measure skeletal muscle mass by MRI analysis pre and post intervention.
Time Frame
20 weeks
Title
Thigh Muscle Composition
Description
MRI skeletal muscle to intermuscular fat ratio
Time Frame
20 weeks
Title
Muscle Strength
Description
maximal isokinetic knee extensor strength (Newton-meters, Nm) using an isokinetic dynamometer (Biodex®)
Time Frame
20 weeks
Title
Muscle Quality
Description
knee extensor strength to thigh muscle area assessed by MRI (Nm/cm2).
Time Frame
20 weeks
Title
Quality of Life Measured by Kansas City Cardiomyopathy Questionnaire (KCCQ) Overall Summary Score
Description
The KCCQ Overall Summary Summary Score is a heart failure disease-specific quality of life measure encompassing domains of physical limitation, HF symptoms, quality of life, and social limitation scored on a scale of 0-100 with higher scores indicating better health status.
Time Frame
20 weeks
Title
Quality of Life Measured by Short Form 36 Item Questionnaire (SF-36)
Description
The SF-36 is a quality of life assessment with 2 component scores (Physical Composite Score and Mental Composite Score) ranging 0-100 with higher scores indicating better health status.
Time Frame
20 weeks
Other Pre-specified Outcome Measures:
Title
Mitochondrial Content
Description
Porin citrate synthase pre and post intervention.
Time Frame
20 weeks
Title
Mitochondrial Function
Description
respiratory control ratio and mitofusin 2 concentration.pre and post intervention.
Time Frame
20 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 60 years or older Ejection fraction ≥ 50% Left Ventricular Diastolic Dysfunction ≥ grade 1 BMI ≥ 28 kg/m2 HF symptoms/ signs by cardiologist review, using NHANES HF Clinical Score >/= 3 or Rich et al. criteria for HF Exclusion Criteria: Valvular heart disease as the primary etiology of CHF (congestive heart failure) Significant change in cardiac medication or Heart Failure symptoms <6 weeks Hospitalization or urgent care visit <6 weeks Uncontrolled hypertension Uncontrolled diabetes Evidence of significant Chronic Obstructive Pulmonary Disease (COPD) Recent or debilitating stroke Cancer or other noncardiovascular conditions with life expectancy less than 2 years Significant anemia (<10 g/dL Hgb) Significant renal insufficiency (eGFR <30 mL/min/1.73m2) Pregnant or of child-bearing potential Psychiatric disease- uncontrolled major psychoses, depressions, dementia, or personality disorder Plans to leave area within the study period Refuses informed consent -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dalane W Kitzman, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wake Forest Baptist Health
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27157
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36314122
Citation
Brubaker PH, Nicklas BJ, Houston DK, Hundley WG, Chen H, Molina AJA, Lyles WM, Nelson B, Upadhya B, Newland R, Kitzman DW. A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2023 Feb;16(2):e010161. doi: 10.1161/CIRCHEARTFAILURE.122.010161. Epub 2022 Oct 31.
Results Reference
derived

Learn more about this trial

Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)

We'll reach out to this number within 24 hrs